Drug Trial Radar · NCT00797966
Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Last checked: Nov 19, 2026Latest source record: Feb 29, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
850
Actual
Start
May 2009
Primary completion
Jun 2010
Study completion Jul 2010
Sponsor
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
- Sponsor type
- Industry
- First posted
- Nov 25, 2008
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary: To compare the efficacy of OPC-34712 to placebo as adjunctive treatment to an assigned open-label marketed antidepressant treatment (ADT)in patients who demonstrate an incomplete response to a prospective eight week trial of the same assigned open-label marketed ADT.
Conditions
- Major Depressive Disorder
Interventions
OPC-34712Drug
Tablets, Oral, 1 - 4 mg OPC-34712 variable dose once daily, 14 weeks
PlaceboDrug
Tablets, Oral, 1- 4 mg OPC-34712 once daily, 14 weeks
ADTDrug
Tablets, 10 - 225 mgs, dose once daily, 14 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From the End of Phase A (Week 8 Visit) to the End of Phase B (Week 14 Visit) in Montgomery Asberg Depression Rating Scale (MADRS) Total Score.Time frame: Week 8 to Week 14
Locations
50 sites in 1 country. Site status is shown where the registry gives one.
Pacific Clinical Research Medical Group
Arcadia, California
Southwestern Research
Beverly Hills, California
Synergy Escondido
Escondido, California
Collaborative Neuroscience Network Inc.
Garden Grove, California
Synergy Clinical Research Center
National City, California
Excell Research
Oceanside, California
Affiliated Research Institute
San Diego, California
California Neuroscience Research Medical Group, Inc.
Sherman Oaks, California
Radiant Research Center
Denver, Colorado
Florida Clinical Research Center, LLC
Bradenton, Florida
CNS Clinical Research Group
Coral Springs, Florida
Gulfcoast Clinical Research Center
Fort Myers, Florida
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida
Accurate Clinical Trials
Kissimee, Florida
Clinical Neurosciences Solutions
Orlando, Florida
Stedman Clinical Trials
Tampa, Florida
University of South Florida College of Medicine Psychiatry Center
Tampa, Florida
Janus Center
West Palm Beach, Florida
Carman Research
Smyrna, Georgia
Uptown Research Institute
Chicago, Illinois
Midwest Center for Neurobehavioral Medicine
Oakbrook Terrace, Illinois
The Davis Clinic, PC
Indianapolis, Indiana
Vince & Associates Clinical Research
Overland Park, Kansas
Pharmasite Research, Inc.
Baltimore, Maryland
Bioscience Research
Mount Kisco, New York
Eastside Comprehensive Medical Center
New York, New York
Medical & Behavioral Health Research, PC
New York, New York
Finger Lakes Clinical Research
Rochester, New York
Carolinas HealthCare - Behavioral Heath Center
Charlotte, North Carolina
NorthCoast Clinical Trials, Inc
Beachwood, Ohio
Neuro-Behavioral Clinical Research, Inc
Canton, Ohio
Patient Priority Clinical Sites, LLC
Cinncinnati, Ohio
Midwest Clinical Research Center
Dayton, Ohio
NorthStar Medical Research, LLC
Middleburg Heights, Ohio
Summitt Research Network (Oregon)
Portland, Oregon
Suburban Research Associates
Media, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania
USC School of Medicine- Department of Neuropsychiatry and Behavioral Science
Columbia, South Carolina
Clinical Neurosciences Solutions, Inc.
Memphis, Tennessee
Community Clinical Research, Inc.
Austin, Texas
Showing 40 of 50 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.